Increased Risk for Herpes Simplex Virus Infection Noted in Systemic Lupus Erythematosus
Risk factors included older age, history of mucocutaneous infection, and intravenous or oral steroid therapy.
Systemic Lupus Erythematosus
Anti-Rituximab Antibodies Predictive of Infusion-Related Reactions in SLE
Researchers investigated how the presence of antidrug antibodies relates to infusion-related reactions and the effectiveness of rituximab therapy in SLE.
Fatigue Assessment Scale Validated in Systemic Lupus Erythematosus
The Fatigue Assessment Scale was validated as a reliable and simple tool to assess fatigue in systemic lupus erythematosus.
Systemic Hypertension May Be a Risk Factor for PAH in Patients With SLE
The development of pulmonary arterial hypertension in patients with SLE is a poor prognostic factor, but systemic hypertension may be a predictive factor for PAH in the SLE population.
Managing Systemic Lupus Erythematosus: Updated 2019 EULAR Recommendations Released
EULAR has released updated 2019 recommendations for the management of systemic lupus erythematosus.
Screening Factors Identifying Those at Higher Risk for Transition to Classified SLE
Researchers identified useful screening factors for identifying at-risk individuals for follow-up rheumatologic assessment or inclusion in prospective studies.
Lupus Low Disease Activity State Associated With Reduced Damage, Lower Mortality in SLE
Researchers observed a reduction in mortality in patients with SLE who achieve a low disease activity state.
Belimumab Demonstrates Long-Term Safety, Efficacy in Systemic Lupus Erythematosus
Belimumab was well tolerated with no new safety concerns, and efficacy was maintained through 13 years of treatment.
Predictors of Remission, Low Disease Activity State Identified in SLE
Researchers examined predictors of remission and low disease activity state in systemic lupus erythematosus.
Ethnicity May Not Contribute to Clinical Differences Between Adult-, Childhood-Onset SLE
Researchers sought to determine whether ethnic differences contribute to the differences in clinical presentation between patients with childhood-onset vs adult-onset SLE.
Next post in Systemic Lupus Erythematosus
